Early Drug Development Group

Organisation	Early Drug Development Group
Profile type	Request (Organisation looking for network)
P2P Networks involved	0
Expertise	Early Drug Development Group (E2DG) is specialized in the early development of novel leads and targets in oncology. E2DG preclinical and clinical operations structure relies on an interdisciplinary team of medical oncologists, pharmacologists and molecular biology experts. In this sense, we are capable of offering professional services covering all stages of the early drug development program in oncology, from lead optimization to Phase I clinical trials. With more than 20 years of long track record in oncology drug development, we worked in the evaluation of over 20 different oncology leads (at least 8 first-in-man), covering both small molecules and monoclonal antibodies.
Contact person name	Maria Eugenia Riveiro
Contact person email	eugenia.riveiro@e2dg.com
Country	France
Website	www.e2dg.com